Akums Drugs To Launch IPO Worth ₹1,856 Cr | Management On Growth & Capex Roadmap | ET Now

Akums Drugs, a leading pharmaceutical company, is set to launch an Initial Public Offering (IPO) worth ₹1,856 crore. In an exclusive interview with ET Now, the company's management discusses its plans for growth and capital expenditure (capex) roadmap. The IPO is expected to provide the company with the necessary funds to fuel its expansion and enhance its market presence. The management highlights the strategic initiatives undertaken to drive growth, including research and development, expansion of manufacturing facilities, and strengthening of distribution networks. They also shed light on the company's focus on innovation, quality, and compliance with regulatory standards. The discussion offers insights into Akums Drugs' vision for the future, emphasizing its commitment to providing affordable and high-quality healthcare solutions. As the IPO launch approaches, investors and stakeholders eagerly anticipate the potential of Akums Drugs' growth trajectory and its impact on the pharmaceutical industry.

#arkumsdrugsipo #pharmasector #topstocks #etnow #topnews #stockmarket #businessnews #sharemarketnews

Subscribe To ET Now For Latest Updates On Stocks, share market, business News, Trading, Crypto Updates | https://bit.ly/SubscribeToETNow

To Stay Updated Download the Times Now App :-
Android Google Play : https://goo.gl/zJhWjC
Apple App Store : https://goo.gl/d7QBQZ

Social Media Links :-
Twitter - http://goo.gl/hA0vDt
Facebook - http://goo.gl/5Lr4mC
G+ - http://goo.gl/hYxrmj
Website - www.etnownews.com

Subscribe Now To Our Network Channels:-
Times Now: https://bit.ly/SubscribeToTimesNow
Mirror Now: https://bit.ly/SubscribeToMirrorNow